The US pharmaceutical company Viatris has informed the Russian Ministry of Industry and Trade that the supply of the drug Viagra, in tablet format, has been suspended in the Russian market.

"Viatris LLC has informed us about the suspension of the supply of the drug Viagra in the pharmaceutical form of a pill", said the ministry, quoted by the Russian news agency TASS.

According to the American pharmaceutical company, the decision was taken after the business was influenced by economic sanctions imposed on Russia after its invasion of Ukraine. "Trade control, sanctions, the supply chain, and other challenges related to the conflict have impacted our operations," quoted The Sun.

The Russian authorities mentioned that domestic pharmaceutical companies have the capacity to carry out clinical trials with the drug, which has sildenafil as its active ingredient, in order to produce its own two versions of Viagra and ensure local production.